$331 Million is the total value of New Leaf Venture Partners, L.L.C.'s 19 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 9.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DCPH | Sell | DECIPHERA PHARMACEUTICALS INC | $104,360,000 | +12.8% | 3,074,825 | -25.1% | 31.57% | +27.3% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $56,384,000 | -35.3% | 1,996,588 | -24.0% | 17.05% | -27.0% |
| ARVN | ARVINAS INC | $49,200,000 | -2.0% | 2,283,048 | 0.0% | 14.88% | +10.6% | |
| HARP | HARPOON THERAPEUTICS INC | $39,906,000 | +5.1% | 2,921,405 | 0.0% | 12.07% | +18.6% | |
| APTX | APTINYX INC | $11,482,000 | +4.5% | 3,290,079 | 0.0% | 3.47% | +17.9% | |
| STIM | Sell | NEURONETICS INC | $11,435,000 | -40.8% | 1,376,006 | -10.8% | 3.46% | -33.1% |
| ALEC | Sell | ALECTOR INC | $9,223,000 | -38.4% | 639,569 | -18.8% | 2.79% | -30.5% |
| ITRM | ITERUM THERAPEUTICS PLC | $8,403,000 | -16.1% | 1,456,303 | 0.0% | 2.54% | -5.3% | |
| OBSV | OBSEVA SA | $7,501,000 | -26.4% | 900,501 | 0.0% | 2.27% | -16.9% | |
| ARAV | ARAVIVE INC | $7,280,000 | +25.0% | 970,659 | 0.0% | 2.20% | +41.1% | |
| AVRO | Buy | AVROBIO INC | $4,456,000 | +27.1% | 315,550 | +46.4% | 1.35% | +43.6% |
| CHMA | Buy | CHIASMA INC | $3,642,000 | +21.9% | 735,700 | +83.9% | 1.10% | +37.6% |
| XFOR | X4 PHARMACEUTICALS INC | $3,622,000 | -15.3% | 285,000 | 0.0% | 1.10% | -4.4% | |
| NERV | MINERVA NEUROSCIENCES INC | $3,484,000 | +37.7% | 449,500 | 0.0% | 1.05% | +55.5% | |
| CMRX | CHIMERIX INC | $3,173,000 | -45.6% | 1,350,000 | 0.0% | 0.96% | -38.6% | |
| UMRX | UNUM THERAPEUTICS INC | $2,586,000 | -45.0% | 1,795,545 | 0.0% | 0.78% | -38.0% | |
| CRNX | Sell | CRINETICS PHARMACEUTICALS INC | $2,121,000 | -49.4% | 141,000 | -15.9% | 0.64% | -42.9% |
| SRRA | SIERRA ONCOLOGY INC | $1,960,000 | -30.3% | 5,020,446 | 0.0% | 0.59% | -21.2% | |
| PDSB | PDS BIOTECHNOLOGY CORP | $396,000 | -43.6% | 117,242 | 0.0% | 0.12% | -36.2% | |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -402,118 | -100.0% | -0.07% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -732,774 | -100.0% | -0.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.